Abstract：Objective To investigate the correlation betweenCHA2DS2-VASc score and recurrence of paroxysmal atrial fibrillation(PAF) after radiofrequency catheter ablation(RFCA) and examining the prognostic value of CHA2DS2-VASc score for recurrence of PAF in patients of different sexes after radiofrequency catheter ablation. [WTHZ]Methods[WT]One hundred and two patients diagnosed with PAF were analyzed in this study. Patients were categorized into two groups that were male group and female group. Recurrence of PAF were confirmed by electrocardiogram or dynamic electrocardiogram through regular followup. Multivariate Cox proportional hazards as performed to examine the relationship between CHA2DS2-VASc score and the recurrence of PAF. KaplanMeier estimation with a Logrank test was used for analysis of the influence of different sexes on recurrence of PAF and comparison of the accuracy, sensitivity, specificity, positive and negative predictive value of predicting AF recurrence when CHA2DS2-VASc score = 2 or 3. Results After a mean followup of twelve months, atrial fibrillation recurrence rate was 28.4%. Following multivariate Cox analysis，CHA2DS2-VASc score was confirmed to be the independent risk factor for recurrence of atrial fibrillation（RR1.896，95% CI 1.3852.596，P＝0.000）.Through multivariate Cox analysis, the recurrence rates of male and female groups were 25.8% and 33.3% , respectively. For male group, the accuracy, sensitivity, specificity, positive and negative predictive value of predicting AF recurrence were 0.637, 0.706, 0.612, 0.387 and 0.857 when CHA2DS2-VASc score = 2,and were 0.742, 0.353, 0.878, 0.500 and 0.796 when CHA2DS2-VASc score = 3. For female group, the accuracy,sensitivity, specificity, positive and negative predictive values of predicting AF recurrence were 0.556, 0.917, 0.375, 0.423 and 0.900 when CHA2DS2-VASc score = 2, and were 0.667, 0.583, 0.708, 0.500 and 0.773 when CHA2DS2-VASc score = 3. Conclusion Increased CHA2DS2-VASc score levels of patients with PAF undergoing RFCA were associated with a higher rate of recurrence of atrial fibrillation. CHA2DS2VASc score =2, both for males and females, as a standard for predicting recurrence has clinical significance.
张其银, 张敬云, 曾现生, 张宇祯, 惠杰. CHA2DS2-VASc评分与不同性别阵发性房颤患者导管射频消融疗效的相关性研究[J]. 实用心电学杂志, 2015, 24(6): 431-436.
ZHANG Qi-Yin, ZHANG Jing-Yun, ZENG Xian-Sheng, ZHANG Yu-Zhen, HUI Jie. Relation of CHA2DS2-VASc score to the efficacy of radiofrequency catheter ablation for patients of different sex with paroxysmal atrial fibrillation. JOURNAL OF PRACTICAL ELECTROCARDIOLOGY, 2015, 24(6): 431-436.
[1] January CT，Wann LS，Alpert JS，et al.2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of theAmerican College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society[J].J Am Coll Cardiol，2014，64(21):2305-2307.[2] Falsetti L，Viticchi G，Tarquinio N，et al. CHA2DS2VASc in the prediction of early atrial fibrillation relapses after electrical or pharmacologicalcardioversion[J].J Cardiovasc Med(Hagerstown)，2014，15(8):636-641.[3] Olesen JB，TorpPedersen C，Hansen ML，et al.The value of the CHA2DS2VASc score for refining stroke risk stratification in patients with atrialfibrillation with a CHADS2 score 01:a nationwide cohort study[J].Thromb Haemost，2012，107(6):1172-1179.[4] Mason PK，Lake DE，Dimarco JP，et al.Impact of the CHA2DS2VASc score on anticoagulation recommendations for atrial fibrillation[J].Am J Med，2012，125(6)：603.e1-e6.[5] Jacobs V，May HT，Bair TL，et al.The impact of risk score (CHADS2 versus CHA2DS2VASc) on longterm outcomes after atrial fibrillation ablation[J].Heart Rhythm，2015，12(4):681-686.[6] January CT，Wann LS，Alpert JS，et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary:a report ofthe American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society[J].Circulation，2014，130(23):2071-2104.[7] 李广平，焦占全.心房颤动相关危险因素的新认识[J].中华心律失常学杂志，2009，13(3):223-225. [8] Vatan MB，Ylmaz S，Agac MT，et al. Relationship between CHA2DS2VASc score and atrial electromechanical function in patients with paroxysmal atrialfibrillation: A pilot study[J]. J Cardiol，2015，66(5):382-387.[9] Nar G，ínci S，Aksan G，et al. The relationships between atrial electromechanical delay and CHA2DS2VASc score in patients diagnosed with paroxysmal AF[J]. Echocardiography，2015，32(9):1359-1366.[10] Vasamreddy CR，Dalal D，Dong J，et al. Symptomatic and asymptomatic atrial fibrillation in patients undergoing radiofrequency catheter ablation[J].JCardiovasc Electrophysiol，2006，17(2):134-139.[11] Mulder AA，Wijffels MC，Wever EF，et al.Arrhythmia detection after atrial fibrillation ablation: value of incremental monitoring time[J]. Pacing ClinElectrophysiol，2012，35(2):164-169.[12] Manganiello S，Anselmino M，Amellone C，et al. Symptomatic and asymptomatic longterm recurrences following transcatheter atrial fibrillation ablation[J]. Pacing Clin Electrophysiol，2014，37(6):697-702.
2015, Vol. 24 
